The activating Ly49W and inhibitory Ly49G NK cell receptors display similar affinities for identical MHC class I ligands

Immunogenetics

Volumn 66, Issue 7-8, 2014, Pages 467-477

  Ma, Brian J ^a   Craveiro Salvado, Carla M ^a   Kane, Kevin P ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Activating Ly49 receptor; Binding affinity; Inhibitory Ly49 receptor; NK cell; SPR

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LY 49 G RECEPTOR; LY 49 W RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A; NATURAL KILLER CELL RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING KINETICS; EFFECTOR CELL; ENZYME ACTIVATION; ENZYME INHIBITION; GENETIC SIMILARITY; GENETIC VARIABILITY; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MOUSE STRAIN; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; RECEPTOR AFFINITY; REGULATORY MECHANISM; SURFACE PLASMON RESONANCE;

MURINAE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; HISTOCOMPATIBILITY ANTIGEN H-2D; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOGENETIC PHENOMENA; KILLER CELLS, NATURAL; LIGANDS; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MOLECULAR SEQUENCE DATA; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SOLUBILITY; SPECIES SPECIFICITY; SURFACE PLASMON RESONANCE;

EID: 84904265494     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-014-0777-2     Document Type: Article

References (65)

1. Abi-Rached L, Parham P (2005) Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med 201(8):1319-1332 (Pubitemid 40629074)
2. Adams EJ, Juo ZS, Venook RT, Boulanger MJ, Arase H, Lanier LL, Garcia KC (2007) Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. Proc Natl Acad Sci U S A 104(24):10128-10133 (Pubitemid 47175274)
3. Anderson SK, Dewar K, Goulet ML, Leveque G, Makrigiannis AP (2005) Complete elucidation of a minimal class IMHC natural killer cell receptor haplotype. Genes Immunol 6(6):481-492 (Pubitemid 43090506)
4. Beckett D, Kovaleva E, Schatz PJ (1999) A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation. Protein Sci 8(4):921-929 (Pubitemid 29165423)
5. Belanger S, Tai LH, Anderson SK, Makrigiannis AP (2008) Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome. Genes Immunol 9(6):509-521
6. Brauner H, Elemans M, Lemos S, Broberger C, Holmberg D, Flodström-Tullberg M, Kärre K, Höglund P (2010) Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice. J Immunol 184(5):2272-2280
7. Brennan J, Mahon G, Mager DL, Jefferies WA, Takei F (1996) Recognition of class I major histocompatibility complex molecules by Ly-49: specificities and domain interactions. J Exp Med 183(4):1553-1559
8. Bridgeman JS, Sewell AK, Miles JJ, Price DA, Cole DK (2012) Structural and biophysical determinants of αβ T-cell antigen recognition. Immunology 135(1):9-18
9. Campbell KS, Hasegawa J (2013) Natural killer cell biology: an update and future directions. J Allergy Clin Immunol 132(3):536-544
10. Carbone FR, Bevan MJ (1989) Induction of ovalbumin-specific cytotoxic Tcells by in vivo peptide immunization. J Exp Med 169(3):603-612 (Pubitemid 19085807)
11. Carlyle JR, Mesci A, Fine JH, Chen P, Belanger S, Tai LH, Makrigiannis AP (2008) Evolution of the Ly49 and Nkrp1 recognition systems. Semin Immunol 20(6):321-330
12. Carnaud C, Gombert J, Donnars O, Garchon H, Herbelin A (2001) Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex. J Immunol 166(4):2404-2411 (Pubitemid 32173475)
13. Cheng TP, French AR, Plougastel BF, Pingel JT, Orihuela MM, Buller ML, Yokoyama WM (2008) Ly49h is necessary for genetic resistance to murine cytomegalovirus. Immunogenetics 60(10):565-573
14. Dam J, Guan R, Natarajan K, Dimasi N, Chlewicki LK, Kranz DM, Schuck P, Margulies DH, Mariuzza RA (2003) Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b). Nat Immunol 4(12):1213-1222 (Pubitemid 37540690)
15. Deng L, Cho S, Malchiodi EL, Kerzic MC, Dam J, Mariuzza RA (2008) Molecular architecture of the MHC-binding site of Ly49 natural killer cell receptors. J Biol Chem 283(24):16840-16849
16. Foley B, De Santis D, Lathbury L, Christiansen F, Witt C (2008) KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals. Int Immunol 20(4):555-563 (Pubitemid 351426049)
17. Franksson L, Sundbäck J, Achour A, Bernlind J, Glas R, Kärre K (1999) Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49C. Eur J Immunol 29(9):2748-2758 (Pubitemid 30098999)
18. Frazier WR, Steiner N, Hou L, Dakshanamurthy S, Hurley CK (2013) Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand. J Immunol 190(12):6198-6208
19. Garboczi DN, Hung DT, Wiley WC (1992) HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci U S A 89(8):3429-3433
20. Hanke T, Takizawa H, McMahon CW, Busch DH, Pamer EG, Miller JD, Altman JD, Liu Y, Cado D, Lemonnier FA, Bjorkman PJ, Raulet DH (1999) Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11(1):67-77 (Pubitemid 29359958)
21. Held W, Kunz B (1998) An allele-specific, stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC- specific NK cell receptor repertoire. Eur J Immunol 28(8):2407-2416 (Pubitemid 28362715)
22. Kaiser BK, Barahmand-Pour F, Paulsene W, Medley S, Geraghty DE, Strong RK (2005) Interactions between NKG2x immunoreceptors and HLA-E ligands display overlapping affinities and thermodynamics. J Immunol 174(5):2878-2884 (Pubitemid 40279705)
23. Kane KP (1994) Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J Exp Med 179(3):1011-1015 (Pubitemid 24065660)
24. Kielczewska A, Pyzik M, Sun T, Krmpotic A, Lodoen MB, Munks MW, Babic M, Hill AB, Koszinowski UH, Jonjic S, Lanier LL, Vidal SM (2009) Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J Exp Med 206(3):515-523
25. Kubo S, Yohjiro I, Naoshi I, Ryuji N, Mitarai T, Maruyama N (1993) The gene encoding mouse lymphocyte antigen Ly-49: structural analysis and the 5′-flanking sequence. Gene 136(1-2):329-331
26. Kubota A, Kubota S, Lohwasser S, Mager DL, Takei F (1999) Diversity of NK cell receptor repertoire in adult and neonatal mice. J Immunol 163(1):212-216 (Pubitemid 29295843)
27. Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23:225-274
28. Lavender KJ, MA BJ, Silver ET, Kane KP (2004) The rat RT1-A1cMHC molecule is a xenogeneic ligand recognized by the mouse activating Ly-49W and inhibitory Ly-49G receptors. J Immunol 172(6):3518-3526
29. Li H, Peng SL, Cui Y, Fu QX, Zhou Y, Wang QL, Zhan LS, Zhong S (2010) Kinetics of interaction of HLA-B2705 with natural killer cell immunoglobulin-like receptor 3DS1. Protein Pept Lett 17(5):547-554
30. Ljunggren HG, Kärre K (1990) In search of the 'missing self ': MHC molecules and NK cell recognition. Immunol Today 11(7):237-244
31. Lukacher AE, Wilson CS (1998) Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein. J Immunol 160(4):1724-1734 (Pubitemid 28106458)
32. Ma BJ, Kane KP (2011) Recognition of class I MHC by a rat Ly49 NK cell receptor is dependent on the identity of the P2 anchor amino acid of bound peptide. J Immunol 187(6):3267-3276
33. Maenaka K, Juji T, Nakayama T, Wyer JR, Gao GF, Maenaka T, Zaccai NR, Kikuchi A, Yabe T, Tokunaga K, Tadokoro K, Stuart DI, Jones EY, van der Merwe PA (1999) Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J Biol Chem 274(40):28329-28334
34. Makrigiannis AP, Anderson SK (2001) The murine Ly49 family: form and function. Arch Immunol Ther Exp 49(1):47-50 (Pubitemid 33611196)
35. Makrigiannis AP, Gosselin P, Mason LH, Taylor LS, McVicar DW, Ortaldo JR, Anderson SK (1999) Cloning and characterization of a novel activating Ly49 closely related to Ly49A. J Immunol 163(9):4931-4938 (Pubitemid 29501259)
36. Makrigiannis AP, Etzler J, Winkler-Pickett R, Mason A, Ortaldo JR, Anderson SK (2000) Identification of the Ly49L protein: evidence for activating counterparts to inhibitory Ly49 proteins. J Leukoc Biol 68(5):765-771
37. Makrigiannis AP, Pau AT, Schwartzberg PL, McVicar DW, Beck TW, Anderson SK (2002) A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics 79(3):437-444 (Pubitemid 34211952)
38. Makrigiannis AP, Rousselle E, Anderson SK (2004) Independent control of Ly49g alleles: implications for NK cell repertoire selection and tumor cell killing. J Immunol 172(3):1414-1425 (Pubitemid 38116783)
39. Mandelboim O, Davis DM, Reyburn HT, Vales-Gomez M, Sheu EG, Pazmany L, Strominger JL (1996) Enhancement of class IIrestricted T cell responses by costimulatory NK receptors for class I MHC proteins. Science 274(5295):2097-2100 (Pubitemid 27020706)
40. McVicar DW, Taylor LS, Gosselin P, Willette-Brown J, Mikhael AI, Geahlen RL, Nakamura MC, Linnemeyer P, Seaman WE, Anderson SK, Ortaldo JR, Mason LH (1998) DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J Biol Chem 273(49):32934-32942 (Pubitemid 28557686)
41. Mehta IK, Smith HRC, Wang J, Margulies DH, Yokoyama WM (2001) A "chimeric" C57L-derived Ly49 inhibitory receptor resembling the Ly49D activating receptor. Cell Immunol 209(1):29-41 (Pubitemid 32568564)
42. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L (1995) Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 182(3):875-884
43. Myszka DG (1999) Improving biosensor analysis. J Mol Recognit 12(5):279-284
44. Nakamura MC, Niemi EC, Fisher MJ, Shultz LD, Seaman WE, Ryan JC (1997) Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J Exp Med 185(4):673-684 (Pubitemid 27098152)
45. Nakamura MC, Linnemeyer PA, Niemi EC, Mason LH, Ortaldo JR, Ryan JC, Seaman WE (1999) Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity. J Exp Med 189(3):493 - 500
46. d: identification of a site distinct from the TCR site. Immunity 11(5):591-601
47. Saleh A, Davies GE, Pascal V, Wright PW, Hodge DL, Cho EH, Lockett SJ, Abshari M, Anderson SK (2004) Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity 21(1):55-66 (Pubitemid 38925267)
48. Schatz PJ (1993) Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Biotechnology 11(10):1138-1143
49. Shirai M, Pendleton CD, Berzofsky JA (1992) Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. J Immunol 148(6):1657-1667
50. Silver ET, Gong DE, Chang CS, Amrani A, Santamaria P, Kane KP (2000) Ly-49P activates NK-mediated lysis by recognizing H-2Dd. J Immunol 165(4):1771-1781 (Pubitemid 30643126)
51. Silver ET, Gong D, Hazes B, Kane KP (2001) Ly-49W, an activating receptor of nonobese diabetic mice with close homology to the inhibitory receptor Ly-49G, recognizes H-2D(k) and H-2D(d). J Immunol 166(4):2333-2341 (Pubitemid 32173466)
52. Silver ET, Lavender KJ, Gong DE, Hazes B, Kane KP (2002) Allelic variation in the ectodomain of the inhibitory Ly-49G2 receptor alters its specificity for allogeneic and xenogeneic ligands. J Immunol 169(9):4752-4760 (Pubitemid 35217137)
53. Smith KM, Wu J, Bakker AB, Phillips JH, Lanier LL (1998) Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J Immunol 161(1):7-10 (Pubitemid 28285499)
54. Smith HR, Chuang HH, Wang LL, Salcedo M, Heusel JW, Yokoyama WM (2000) Nonstochastic coexpression of activation receptors on murine natural killer cells. J Exp Med 191(8):1341-1354 (Pubitemid 30227122)
55. Stewart CA, Laugier-Anfossi F, Vely F, Saulquin X, Riedmuller J, Tisserant A, Gauthier L, Romagne F, Ferracci G, Arosa FA, Moretta A, Sun PD, Ugolini S, Vivier E (2005) Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A 102(37):13224-13229 (Pubitemid 41325005)
56. Tomasello E, Olcese L, Vely F, Geourgeon C, Blery M, Moqrich A, Gautheret D, Djabali M, Mattei MG, Vivier E (1998) Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12. J Biol Chem 273(51):34115-34119 (Pubitemid 29008881)
57. Tormo J, Nataranjan K, Margulies DH, Mariuzza RA (1999) Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402(6762):623-631 (Pubitemid 129516325)
58. Trowsdale J (2001) Genetic and functional relationships between MHC and NK receptor genes. Immunity 15(3):363-374
59. Valés-Gómez M, Reyburn HT, Mandelboim M, Strominger JL (1998) Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. Immunity 9(3):337-344 (Pubitemid 28462754)
60. Vales-Gomez M, Reyburn HT, Erskine RA, Strominger J (1998) Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc Natl Acad Sci U S A 95(24):14326-14331 (Pubitemid 28549366)
61. Vales-Gomez M, Reyburn HT, Erskine RA, Lopez-Botet M, Strominger JL (1999) Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J 18(15):4250-4260 (Pubitemid 29364127)
62. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D ' Andrea A, Phillips JH, Lanier LL, Parham P (1997) Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7(6):739-751 (Pubitemid 28064888)
63. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO (1995) Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 3(6):801-809 (Pubitemid 26092193)
64. Wang J, Whitman MC, Natarajan K, Tormo J, Mariuzza RA, Margulies DH (2002) Binding of the natural killer cell inhibitory receptor Ly49A to its major histocompatibility complex class I ligand. Crucial contacts include both H-2Dd AND beta 2-microglobulin. J Biol Chem 277(2):1433-1442 (Pubitemid 34968898)
65. Warren HS, Campbell AJ, Waldron JC, Lanier LL (2001) Biphasic response of NK cells expressing both activating and inhibitory killer Ig-like receptors. Int Immunol 13(8):1043-1052 (Pubitemid 32750507)